Klavax BID 400 mg + 57 mg/5 ml prašak za oralnu suspenziju
| Name | Klavax BID 400 mg + 57 mg/5 ml prašak za oralnu suspenziju |
|---|---|
| Marketing Authorisation Number | HR-H-558237914 |
| Active Substance | amoksicilin trihidrat kalijev klavulanat |
| Composition | 5 ml suspenzije sadrži 400 mg amoksicilina u obliku amoksicilin trihidrata i 57 mg klavulanske kiseline u obliku kalijevog klavulanata |
| Pharmaceutical Form | prašak za oralnu suspenziju |
| Manufacturer | mibe GmbH Arzneimittel, Brehna, Njemačka |
| Marketing Authorisation Holder | Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska |
| Marketing Authorisation Date | 10.01.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/140 |
| Registration Number | 381-12-01/38-20-39 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01CR02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
